Nintedanib in children and adolescents with fibrosing interstitial lung diseases.
- DOI
- 10.1183/13993003.01512-2022
- Published
- 2023 Feb
- Container
- The European respiratory journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1183/13993003.01512-2022,
title = {Nintedanib in children and adolescents with fibrosing interstitial lung diseases.},
author = {Deterding R and Young LR and DeBoer EM and Warburton D and Cunningham S and Schwerk N and Flaherty KR and Brown KK and Dumistracel M and Erhardt E and Bertulis J and Gahlemann M and Stowasser S and Griese M and InPedILD trial investigators},
year = {2023},
journal = {The European respiratory journal},
doi = {10.1183/13993003.01512-2022},
url = {https://doi.org/10.1183/13993003.01512-2022}
}RIS
TY - JOUR TI - Nintedanib in children and adolescents with fibrosing interstitial lung diseases. AU - Deterding R AU - Young LR AU - DeBoer EM AU - Warburton D AU - Cunningham S AU - Schwerk N AU - Flaherty KR AU - Brown KK AU - Dumistracel M AU - Erhardt E AU - Bertulis J AU - Gahlemann M AU - Stowasser S AU - Griese M AU - InPedILD trial investigators PY - 2023 JO - The European respiratory journal DO - 10.1183/13993003.01512-2022 UR - https://doi.org/10.1183/13993003.01512-2022 ER -
APA
R, D., LR, Y., EM, D., D, W., S, C., N, S., KR, F., KK, B., M, D., E, E., J, B., M, G., S, S., M, G., & investigators, I. T. (2023). Nintedanib in children and adolescents with fibrosing interstitial lung diseases.. The European respiratory journal. https://doi.org/10.1183/13993003.01512-2022
Source records
- pubmed · retrieved 2026-09-25T07:47:12.484Z